About this episode

Dr. Jennifer Sun discusses the Phase 2 results of tonabersat for diabetic macular edema with Dr. Keyvan Koushan.

In this episode of The Retina Channel Podcast, Dr. Jennifer Sun joins Dr. Keyvan Koushan to discuss the Phase 2 results of DRCR Retina Network Protocol AN evaluating tonabersat for diabetic macular edema. Dr. Sun reviews the rationale behind targeting connexin-43–mediated inflammatory pathways in DME, the key efficacy and safety findings from the study, and the potential implications of this novel oral therapy for future diabetic retinal disease management. The conversation also explores broader trends in DRCR clinical research and emerging treatment paradigms in diabetic eye disease.

More episodes of The Retina Channel Podcast

• E97- Artificial Intelligence in Ophthalmology- Dr. John Kitchens · June 15, 2026 · 29 min
• E95- Real-World Data of Intraocular Inflammation Associated with Faricimab- Dr. Andrea Montesel · March 21, 2026 · 23 min
• E94 – Systemic Drugs & Underrecognized Maculopathy - Dr. Seong Joon Ahn · January 23, 2026 · 24 min
• E93- Slit-Lamp Detection of PVD: A Simpler Way to Diagnose- Dr. Mohsin Ali · December 25, 2025 · 32 min
• E92-3D Heads-up Display Surgery - Dr. David Chow · November 29, 2025 · 55 min
• E91- Inherited Retinal Disorders- Progress Promise and Lessons— Dr. Ioannis Dimopoulos · October 31, 2025 · 1h 4m

Explore listener stats, chart rankings, contacts and more on the The Retina Channel Podcast podcast page.